Skip to main content
FinSpry Logo
FinSpry
LLY logo
LLY
(NYSE)
Eli Lilly and Company
$1,124.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Eli Lilly and Company (LLY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Eli Lilly and Company stock.

Analyst Consensus Rating

Investment consensus from 61 professional research analysts

Consensus Rating

Buy
Based on 61 unique analysts
(79 total ratings in last 90 days)
Very High Confidence10.0:1 Buy/Sell

Average Price Target

$1,359.61
↑ 20.94% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest LLY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kinjel Shah
Zacks Equity Research
BuyInitiates Coverage
-
Keith Speights
The Motley Fool
BuyInitiates Coverage
-
UK
Investing.com
BuyInitiates Coverage
-
DidYouReadThis
StockTwits
SellInitiates Coverage
-
James Halley
The Motley Fool
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Matthew Benjamin
The Motley Fool
BuyInitiates Coverage
-
Indrajit Bandyopadhyay
Zacks Equity Research
HoldInitiates Coverage
-
Prosper Junior Bakiny
The Motley Fool
BuyInitiates Coverage
-
NYSE:LLY
Investing.com
BuyInitiates Coverage
-
Eric Volkman
The Motley Fool
BuyInitiates Coverage
-
Micah Zimmerman
The Motley Fool
BuyInitiates Coverage
-
Johnny_Lever
StockTwits
BuyInitiates Coverage
-
David Jagielski, CPA
The Motley Fool
BuyInitiates Coverage
-
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Sundeep Ganoria
Zacks Equity Research
SellInitiates Coverage
-
JoaoCarvalho
StockTwits
BuyInitiates Coverage
-
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$1420.00 → $1363.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$1438.00 → $1375.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
BuyDowngrades
$1335.00 → $1287.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$1438.00 → $1357.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$1426.00 → $1369.00
Louise Chen
Scotiabank
BuyMaintains
$1300.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$1401.00 → $1322.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$1350.00 → $1410.00
Asad Haider
Goldman Sachs
BuyMaintains
$1283.00 → $1367.00
Shaun Pruitt
Zacks Equity Research
HoldInitiates Coverage
-
Umer Raffat
Evercore ISI Group
HoldMaintains
-
Terence Flynn
Morgan Stanley
BuyReiterates
$1347.00 → $1419.00
VentureBack
StockTwits
BuyInitiates Coverage
-
Michael Yee
UBS
BuyMaintains
$1425.00
Mohit Bansal
Wells Fargo
BuyInitiates Coverage
$1280.00 → $1330.00
Trung Huynh
RBC Capital
BuyMaintains
$1500.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Andrew Rocco
Zacks Equity Research
SellInitiates Coverage
-
clan
StockTwits
BuyInitiates Coverage
-
Lets__Go
StockTwits
BuyInitiates Coverage
-
Nvidia
Investing.com
BuyInitiates Coverage
-
Alex Carchidi
The Motley Fool
BuyInitiates Coverage
-
JuggernautRaider
StockTwits
SellInitiates Coverage
-
Alex7000
StockTwits
BuyInitiates Coverage
-
David Risinger
Leerink Partners
BuyMaintains
-
Lowkeyoptions
StockTwits
BuyInitiates Coverage
-
Bazziggr
StockTwits
SellInitiates Coverage
-
Todd Shriber
TopStockAnalysts
BuyInitiates Coverage
-
Adria Cimino
The Motley Fool
BuyInitiates Coverage
-
Courtney Breen
Bernstein
BuyReiterates
$1300.00 → $1385.00
Daniel Sparks
The Motley Fool
BuyInitiates Coverage
-
Seamus Fernandez
Guggenheim
BuyReiterates
$1235.00 → $1273.00
Emily Field
Barclays
BuyMaintains
$1400.00
Evan Seigerman
BMO Capital
BuyMaintains
$1300.00
Michael Yee
UBS
BuyReiterates
$1250.00 → $1425.00
Ethan Feller
Zacks Equity Research
BuyInitiates Coverage
-
Keith Speights
The Motley Fool
BuyInitiates Coverage
-
Jason Gerberry
BofA Securities
BuyReiterates
$1251.00 → $1334.00
Mohit Bansal
Wells Fargo
BuyMaintains
$1280.00
Nauman Khan
InvestorPlace
BuyInitiates Coverage
-
Matthew Benjamin
The Motley Fool
BuyInitiates Coverage
-
Srikripa Devarakonda
Truist
BuyReiterates
$1281.00 → $1370.00
Parkev Tatevosian
The Motley Fool
BuyInitiates Coverage
-
Trung Huynh
RBC Capital
BuyMaintains
$1250.00 → $1500.00
Terence Flynn
Morgan Stanley
BuyMaintains
$1344.00 → $1347.00
David Jagielski, CPA
The Motley Fool
HoldInitiates Coverage
-
Emily Field
Barclays
BuyMaintains
$1400.00
Chris Schott
JP Morgan
BuyReiterates
$1300.00 → $1400.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$1230.00 → $1350.00
Akash Tewari
Jefferies
BuyMaintains
$1350.00
Brendan Coffey
The Motley Fool
BuyInitiates Coverage
-
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$1376.00 → $1420.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$1387.00 → $1438.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
BuyReiterates
$1294.00 → $1335.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$1376.00 → $1438.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$1358.00 → $1426.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$1358.00 → $1401.00
Courtney Breen
Bernstein
BuyMaintains
$1300.00
David Risinger
Leerink Partners
BuyMaintains
$1119.00 → $1232.00
Kerry Holford
Berenberg Bank
HoldMaintains
$1050.00 → $1135.00
Geoff Meacham
Citi
BuyMaintains
$1500.00
Evan Seigerman
BMO Capital
BuyMaintains
$1300.00

Frequently Asked Questions

What is the analyst consensus rating for LLY?

The analyst consensus rating for LLY is "Buy" based on 61 analyst recommendations.

What is the average price target for LLY?

The average 12-month price target for LLY is $1359.61, representing an upside of 20.9% from the current price of $1124.21.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.